Human kallikrein-related peptidase 12 (KLK12) splice variants discriminate benign from cancerous breast tumors

Our results demonstrate the discriminative value of KLK12sv1/2 and KLK12sv3 between benign and malignant breast tumors as well as their potential favorable prognostic significance in breast adenocarcinoma.